ROP
53
-9
ZBH
65
3
NOV
52
-5
AME
74
-4
DTE
43
5
URBN
48
-6
AMGN
42
-4
IRM
41
3
BEN
50
9
AON
54
2
EQR
54
3
AIZ
82
2
SWKS
38
-2
VZ
44
4
DG
8
-2
GILD
47
-8
HAS
30
-2
STT
64
2
XOM
42
-6
AEP
54
6
ROP
53
-9
ZBH
65
3
NOV
52
-5
AME
74
-4
DTE
43
5
URBN
48
-6
AMGN
42
-4
IRM
41
3
BEN
50
9
AON
54
2
EQR
54
3
AIZ
82
2
SWKS
38
-2
VZ
44
4
DG
8
-2
GILD
47
-8
HAS
30
-2
STT
64
2
XOM
42
-6
AEP
54
6
Financhill
Back

ProShares Short SmallCap600 Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
33

SBB
ProShares Short SmallCap600

Last Price:
14.25
Seasonality Move:
-5.85%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
33
ProShares Short SmallCap600 (SBB) is a Sell

Is ProShares Short SmallCap600 a Buy, Sell or Hold?

  • The current ProShares Short SmallCap600 [SBB] share price is $14.26. The Score for SBB is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SBB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SBB Stock Price Chart

What is ProShares Short SmallCap600's stock price today?

  • The ProShares Short SmallCap600 share price today is $14.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SBB is experiencing buying pressure, which is a positive indicator for future bullish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SBB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 45.52 Sell
Chaikin Money Flow: 896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.04 - 15) Sell
Bollinger Bands (100): (14.51 - 15.71) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SBB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.89 Buy
20-day SMA: 14.51 Sell
50-day SMA: 14.78 Sell
200-day SMA: 15.67 Sell
8-day EMA: 14.11 Buy
20-day EMA: 14.36 Sell
50-day EMA: 14.7 Sell
200-day EMA: 15.65 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ProShares Short SmallCap600 Earnings Growth & SBB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

ProShares Short SmallCap600 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):